If you are using another drug like this one
It sounds like a panacea, but there are caveats the big one being that most injectable peptides have not been thoroughly studied, nor are they FDA-approved
Some patients find themselves skipping workouts or eating out more often than planned
For example, AstraZeneca recently spent $2 billion to license an experimental pill that might have fewer side effects than the injectable treatments
van Ruiten CC, van der Aart-van der Beek AB, IJzerman RG et al (2021) Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: a prespecified secondary analysis of a randomized controlled clinical trial
Insurance coverage and cost are the primary barriers to tirzepatide